|
GB0425248D0
(en)
|
2004-11-16 |
2004-12-15 |
Gw Pharma Ltd |
New use for cannabinoid
|
|
US9168278B2
(en)
|
2004-11-16 |
2015-10-27 |
Gw Pharma Limited |
Use for cannabinoid
|
|
GB2471523A
(en)
|
2009-07-03 |
2011-01-05 |
Gw Pharma Ltd |
Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
|
|
TWI583374B
(zh)
|
2010-03-30 |
2017-05-21 |
Ｇｗ伐瑪有限公司 |
使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
|
|
US8445034B1
(en)
|
2010-11-02 |
2013-05-21 |
Albert L Coles, Jr. |
Systems and methods for producing organic cannabis tincture
|
|
CA2726085A1
(en)
*
|
2010-12-20 |
2012-06-20 |
Bernard Le Foll |
User of marihuana and compounds therein for treating obesity
|
|
GB2487712B
(en)
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
GB2495118B
(en)
|
2011-09-29 |
2016-05-18 |
Otsuka Pharma Co Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
GB2496687A
(en)
*
|
2011-11-21 |
2013-05-22 |
Gw Pharma Ltd |
Tetrahydrocannabivarin (THCV) in the protection of pancreatic islet cells
|
|
US9259449B2
(en)
*
|
2014-01-07 |
2016-02-16 |
Joshua Michael Raderman |
Method for modifying THC content in a lipid-based extract of cannabis
|
|
US10821240B2
(en)
|
2014-02-11 |
2020-11-03 |
Vapor Cartridge Technology Llc |
Methods and drug delivery devices using cannabis
|
|
US9220294B2
(en)
|
2014-02-11 |
2015-12-29 |
Timothy McCullough |
Methods and devices using cannabis vapors
|
|
US9380813B2
(en)
|
2014-02-11 |
2016-07-05 |
Timothy McCullough |
Drug delivery system and method
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
GB2527591A
(en)
*
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD)
|
|
GB2527590A
(en)
*
|
2014-06-27 |
2015-12-30 |
Otsuka Pharma Co Ltd |
Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer
|
|
GB2531278A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
US9539295B2
(en)
|
2014-12-05 |
2017-01-10 |
Bradley Michael Bohus |
Cannabidiol (CBD) enriched alcohol
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
BR112018001310A2
(en)
*
|
2015-07-22 |
2018-09-11 |
Phytopharma International Ltd. |
bee-ingestible compositions, methods of use thereof for the production of honey and honey produced by these
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2548873B
(en)
|
2016-03-31 |
2020-12-02 |
Gw Res Ltd |
Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
|
|
US10499584B2
(en)
|
2016-05-27 |
2019-12-10 |
New West Genetics |
Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2551986A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Parenteral formulations
|
|
TWI753930B
(zh)
|
2016-08-01 |
2022-02-01 |
德商矢倫德國股份有限公司 |
鏈條封閉鏈結
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
WO2018064654A1
(en)
|
2016-10-01 |
2018-04-05 |
James Smeeding |
Pharmaceutical compositions comprising a statin and a cannabinoid and uses thereof
|
|
GB2557921A
(en)
|
2016-12-16 |
2018-07-04 |
Gw Res Ltd |
Use of cannabinoids in the treatment of angelman syndrome
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
GB2564383B
(en)
|
2017-06-23 |
2021-04-21 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
|
|
EP3697409A4
(en)
*
|
2017-10-18 |
2021-06-02 |
Mor Research Applications Ltd. |
CANNABIDIOL AND CHITOSAN COMPOSITIONS AND METHOD OF USE THEREOF
|
|
GB2568929A
(en)
|
2017-12-01 |
2019-06-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
|
GB201806953D0
(en)
|
2018-04-27 |
2018-06-13 |
Gw Res Ltd |
Cannabidiol Preparations
|
|
CN110575447B
(zh)
*
|
2018-06-07 |
2022-11-29 |
汉义生物科技（北京）有限公司 |
一种用于防治糖尿病的药物组合物及其用途
|
|
WO2019232740A1
(zh)
*
|
2018-06-07 |
2019-12-12 |
汉义生物科技（北京）有限公司 |
一种用于防治糖尿病的药物组合物及其用途
|
|
CA3091719A1
(en)
*
|
2018-08-08 |
2020-02-13 |
Neptune Wellness Solutions Inc. |
Cold extraction method for cannabinoids and terpenes from cannabis by organic solvents
|
|
AU2019335372B2
(en)
*
|
2018-09-05 |
2024-12-12 |
Purisys Llc |
Cannabidiol compositions having modified cannabinoid profiles
|
|
WO2020240550A1
(en)
*
|
2019-05-28 |
2020-12-03 |
Bol Pharma Ltd. |
Cannabidiol for treating type 1 diabetes mellitus
|
|
US20210015762A1
(en)
*
|
2019-07-16 |
2021-01-21 |
TRUETIVA, Inc. |
Compositions for treating obesity
|
|
EP4030941A1
(en)
|
2019-09-16 |
2022-07-27 |
Vapor Cartridge Technology LLC |
Drug delivery system with stackable substrates
|
|
US12409131B2
(en)
|
2019-10-03 |
2025-09-09 |
Pike Therapeutics Usa, Inc. |
Transdermal delivery of dronabinol
|
|
CN114650809A
(zh)
|
2019-10-03 |
2022-06-21 |
斯塔顿治疗公司 |
屈大麻酚的透皮递送
|
|
US12016829B2
(en)
|
2019-10-11 |
2024-06-25 |
Pike Therapeutics Inc. |
Pharmaceutical composition and method for treating seizure disorders
|
|
CA3155176A1
(en)
|
2019-10-11 |
2021-04-15 |
Pike Therapeutics, Inc., 1219014 B.C. Ltd. |
Transdermal compositions comprising cannabidiol (cbd) for use in the treatment of seizure disorders
|
|
CA3155181A1
(en)
|
2019-10-14 |
2021-04-22 |
Pike Therapeutics, Inc., 1219014 B.C. Ltd. |
Transdermal delivery of cannabidiol
|
|
US12121617B2
(en)
|
2019-10-14 |
2024-10-22 |
Pike Therapeutics Inc. |
Transdermal delivery of cannabidiol
|
|
US12268699B2
(en)
|
2019-10-14 |
2025-04-08 |
Pike Therapeutics Inc. |
Transdermal delivery of tetrahydrocannabinol
|
|
JP2021061789A
(ja)
*
|
2019-10-15 |
2021-04-22 |
サムライ金沢株式会社 |
食品組成物および飼料組成物
|
|
KR102448514B1
(ko)
*
|
2019-12-10 |
2022-10-05 |
한국 한의학 연구원 |
대마 줄기 추출물을 유효성분으로 함유하는 동맥경화의 예방, 개선 또는 치료용 조성물
|
|
IL272078A
(en)
|
2020-01-16 |
2021-07-29 |
Can Fite Biopharma Ltd |
Cannabinoids for use in treatment
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
KR102393417B1
(ko)
*
|
2020-06-04 |
2022-05-02 |
재단법인 경북바이오산업연구원 |
대마 줄기 추출물을 포함하는 항당뇨용 조성물
|
|
KR102393416B1
(ko)
*
|
2020-06-04 |
2022-05-02 |
재단법인 경북바이오산업연구원 |
대마 뿌리 추출물을 포함하는 항당뇨용 조성물
|
|
KR20210158175A
(ko)
*
|
2020-06-23 |
2021-12-30 |
주식회사 유셀파마 |
대마 줄기 추출물을 유효성분으로 함유하는 고콜레스테롤혈증의 예방, 개선 또는 치료용 조성물
|
|
AU2021318553A1
(en)
|
2020-07-28 |
2023-03-23 |
Impello Biosciences Inc. |
Methods and compositions for altering secondary metabolites in plants
|
|
US11160757B1
(en)
|
2020-10-12 |
2021-11-02 |
GW Research Limited |
pH dependent release coated microparticle cannabinoid formulations
|
|
CA3192962A1
(en)
*
|
2020-11-23 |
2022-05-27 |
Denis Marcel Barron |
Substituted resorcinol compounds as ampk activators, compositions, methods and uses thereof
|
|
US20240082269A1
(en)
*
|
2022-04-20 |
2024-03-14 |
Gregory L. Smith |
Methods and products including specific cannabinoids
|
|
WO2024033521A1
(en)
|
2022-08-12 |
2024-02-15 |
GW Research Limited |
Oral solid dosage forms comprising cannabinoids
|